Literature DB >> 25315712

Detailed characterization of microRNA changes in a canine heart failure model: Relationship to arrhythmogenic structural remodeling.

Yu Chen1, Reza Wakili2, Jiening Xiao3, Chia-Tung Wu4, Xiaobin Luo3, Sebastian Clauss5, Kristin Dawson1, Xiaoyan Qi3, Patrice Naud3, Yan-Fen Shi3, Jean-Claude Tardif3, Stefan Kääb5, Dobromir Dobrev6, Stanley Nattel7.   

Abstract

Heart failure (HF) causes left-atrial (LA) and left-ventricular (LV) remodeling, with particularly-prominent changes in LA that create a substrate for atrial fibrillation (AF). MicroRNAs (miRs) are potential regulators in cardiac remodeling. This study evaluated time-dependent miR expression-changes in LA and LV tissue, fibroblasts and cardiomyocytes in experimental HF. HF was induced in dogs by ventricular tachypacing (varying periods, up to 2weeks). Following screening-microarray, 15 miRs were selected for detailed real-time qPCR assay. Extracellular matrix mRNA-expression was assessed by qPCR. Tachypacing time-dependently reduced LV ejection-fraction, increased LV-volume and AF-duration, and caused tissue-fibrosis with LA changes greater than LV. Tissue miR-expression significantly changed in LA for 10 miRs; in LV for none. Cell-selective analysis showed significant time-dependent changes in LA-fibroblasts for 10/15 miRs, LV-fibroblasts 8/15, LA-cardiomyocytes in 6/15 and LV-cardiomyocytes 3/15. Cell-expression specificity did not predict cell-specificity of VTP-induced expression-changes, e.g. 4/6 cardiomyocyte-selective miRs changed almost exclusively in fibroblasts (miR-1, miR-208b, miR133a/b). Thirteen miRs directly implicated in fibrosis/extracellular-matrix regulation were prominently changed: 9/13 showed fibroblast-selective alterations and 5/13 LA-selective. Multiple miRs changed in relation to associated extracellular-matrix targets. Experimental HF causes tissue and cell-type selective, time-dependent changes in cardiac miR-expression. Expression-changes are greater in LA versus LV, and greater in fibroblasts than cardiomyocytes, even for most cardiomyocyte-enriched miRs. This study, the first to examine time, chamber and cell-type selective changes in an experimental model of HF, suggests that multiple miR-changes underlie the atrial-selective fibrotic response and emphasize the importance of considering cell-specificity of miR expression-changes in cardiac remodeling paradigms.
Copyright © 2014. Published by Elsevier Ltd.

Entities:  

Keywords:  Fibrosis; Heart failure; MicroRNA; Remodeling

Mesh:

Substances:

Year:  2014        PMID: 25315712     DOI: 10.1016/j.yjmcc.2014.10.001

Source DB:  PubMed          Journal:  J Mol Cell Cardiol        ISSN: 0022-2828            Impact factor:   5.000


  18 in total

1.  MicroRNA target for MACC1 and CYR61 to inhibit tumor growth in mice with colorectal cancer.

Authors:  Guiqi Wang; Jingfeng Gu; Yingchao Gao
Journal:  Tumour Biol       Date:  2016-08-04

2.  Differential microRNA-21 and microRNA-221 Upregulation in the Biventricular Failing Heart Reveals Distinct Stress Responses of Right Versus Left Ventricular Fibroblasts.

Authors:  Jeffery C Powers; Abdelkarim Sabri; Dalia Al-Bataineh; Dhruv Chotalia; Xinji Guo; Florence Tsipenyuk; Remus Berretta; Pavithra Kavitha; Heramba Gopi; Steven R Houser; Mohsin Khan; Emily J Tsai; Fabio A Recchia
Journal:  Circ Heart Fail       Date:  2020-01-09       Impact factor: 8.790

Review 3.  Circulating microRNAs fluctuations in exercise-induced cardiac remodeling: A systematic review.

Authors:  Fabian Sanchis-Gomar; Miriam Arnau-Moyano; Lidia Daimiel; Giuseppe Lippi; Roman Leischik; Néstor Vallecillo; Thomas Yvert; Sergio L Jiménez; Catalina Santiago; Helios Pareja-Galeano
Journal:  Am J Transl Res       Date:  2021-12-15       Impact factor: 4.060

Review 4.  Animal Models to Study Cardiac Arrhythmias.

Authors:  Daniel J Blackwell; Jeffrey Schmeckpeper; Bjorn C Knollmann
Journal:  Circ Res       Date:  2022-06-09       Impact factor: 23.213

5.  An Improved microRNA Annotation of the Canine Genome.

Authors:  Luca Penso-Dolfin; Ross Swofford; Jeremy Johnson; Jessica Alföldi; Kerstin Lindblad-Toh; David Swarbreck; Simon Moxon; Federica Di Palma
Journal:  PLoS One       Date:  2016-04-27       Impact factor: 3.240

6.  The Role of MicroRNAs in Antiarrhythmic Therapy for Atrial Fibrillation.

Authors:  Sebastian Clauss; Moritz F Sinner; Stefan Kääb; Reza Wakili
Journal:  Arrhythm Electrophysiol Rev       Date:  2015-12-01

Review 7.  Animal models of arrhythmia: classic electrophysiology to genetically modified large animals.

Authors:  Sebastian Clauss; Christina Bleyer; Dominik Schüttler; Philipp Tomsits; Simone Renner; Nikolai Klymiuk; Reza Wakili; Steffen Massberg; Eckhard Wolf; Stefan Kääb
Journal:  Nat Rev Cardiol       Date:  2019-08       Impact factor: 32.419

8.  Expression Profiling of Circulating MicroRNAs in Canine Myxomatous Mitral Valve Disease.

Authors:  Qinghong Li; Lisa M Freeman; John E Rush; Dorothy P Laflamme
Journal:  Int J Mol Sci       Date:  2015-06-19       Impact factor: 5.923

9.  MicroRNAs as Biomarkers for Acute Atrial Remodeling in Marathon Runners (The miRathon Study--A Sub-Study of the Munich Marathon Study).

Authors:  Sebastian Clauss; Reza Wakili; Bianca Hildebrand; Stefan Kääb; Eva Hoster; Ina Klier; Eimo Martens; Alan Hanley; Henner Hanssen; Martin Halle; Thomas Nickel
Journal:  PLoS One       Date:  2016-02-09       Impact factor: 3.240

10.  Circulating exosome microRNA associated with heart failure secondary to myxomatous mitral valve disease in a naturally occurring canine model.

Authors:  Vicky K Yang; Kerry A Loughran; Dawn M Meola; Christine M Juhr; Kristen E Thane; Airiel M Davis; Andrew M Hoffman
Journal:  J Extracell Vesicles       Date:  2017-07-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.